nach oben

Erschienen in:

01.03.2018 | Case report

Rituximab

Tachycardia as an infusion-related reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Auszug

In a study of 142 patients, a patient [age and sex not stated] was described, who developed tachycardia as an infusion-related reaction during treatment with rituximab [Truxima; dosage and indication not stated; time to reaction onset not clearly stated]. …

Shah R, et al. Evaluation of the safety and tolerability of rapid infusion of biosimilar rituximab Truxima - The University College London Hospitals (UCLH) experience. Blood 130 (Suppl. 1): 3387, Dec 2017 [abstract] - UnitedKingdom

Titel: Rituximab
Tachycardia as an infusion-related reaction: case report
Publikationsdatum: 01.03.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-44152-x

Dabigatran-etexilate/ibrutinib

Case report

Ombitasvir/paritaprevir/ritonavir

Case report

Nevirapine

Case report

Antipsychotics/aripiprazole interaction

Case report

Antiepileptics

Case report

Bisoprolol

Case report

Springer Medizin

Rituximab

Tachycardia as an infusion-related reaction: case report

Auszug

Weitere Artikel der Ausgabe 1/2018

Dabigatran-etexilate/ibrutinib

Ombitasvir/paritaprevir/ritonavir

Nevirapine

Antipsychotics/aripiprazole interaction

Antiepileptics

Bisoprolol

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Dabigatran-etexilate/ibrutinib

Ombitasvir/paritaprevir/ritonavir

Nevirapine

Antipsychotics/aripiprazole interaction

Antiepileptics

Bisoprolol